Literature DB >> 15151482

New European, American and International guidelines for hypertension management: agreement and disagreement.

George S Stergiou1, Eleanna V Salgami.   

Abstract

Hypertension is a leading cause of morbidity and mortality worldwide and its control rates remain poor. In 2003, several official organizations presented new guidelines for hypertension management. These guidelines were developed using an evidence-based interpretation of the available information. Recommendations on hypertension prevention, diagnosis, patients' evaluation, decision to treat, antihypertensive drug selection and goals of treatment are included. There is considerable agreement among the new guidelines and only a few points of disagreement, that are of minor significance. Emphasis has been placed on the simplicity of recommendations in order for them to be easily applied by primary care physicians. This review focuses on the key messages of the 2003 guidelines and the areas of agreement and disagreement among them.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151482     DOI: 10.1586/14779072.2.3.359

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  13 in total

Review 1.  Desirable therapeutic characteristics of an optimal antihypertensive agent.

Authors:  Lisa Mustone Alexander
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  There is a significant relationship between morning blood pressure surge and increased abdominal aortic intima-media thickness in hypertensive patients.

Authors:  Ayse Selcan Koc; Ferıde Fatma Gorgulu; Yurdaer Donmez; Yahya Kemal Icen
Journal:  J Med Ultrason (2001)       Date:  2018-03-13       Impact factor: 1.314

3.  Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients.

Authors:  Mehmet Yavuz Gözükara; Abdurrezzak Börekçi; Mustafa Gür; Nurten Aksoy; Taner Şeker; Onur Kaypaklı; Hakan Uçar; Caner Türkoğlu; Mevlüt Koç; İlyas Makca; Selahattin Akyol; Şahbettin Selek; Murat Çaylı
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

4.  Acute psychological stress, autonomic function, and arterial stiffness among women.

Authors:  Jeongok G Logan; Bethany A Teachman; Xiaoyue Liu; Charles R Farber; Zhenqi Liu; Brian H Annex
Journal:  Int J Psychophysiol       Date:  2020-06-30       Impact factor: 2.997

5.  Association between high-sensitivity troponin T, left ventricular hypertrophy, and myocardial performance index.

Authors:  Onur Kaypakli; Mustafa Gür; Mehmet Yavuz Gözükara; Hakan Uçar; Ali Kivrak; Taner Şeker; Durmuş Yildiray Şahin; Zafer Elbasan; Caner Türkoğlu; Murat Çayli
Journal:  Herz       Date:  2015-06-19       Impact factor: 1.443

Review 6.  Combination pharmacotherapy in hypertension.

Authors:  George S Stergiou
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

7.  The influence of circadian blood pressure changes on aortic distensibility and left ventricular diastolic function in hypertensive individuals.

Authors:  Dogan Erdogan; Hakan Gullu; Mustafa Caliskan; Ibrahim Yildirim; Semra Baycan; Ozgur Ciftci; Haldun Muderrisoglu
Journal:  Int J Cardiovasc Imaging       Date:  2005-07-20       Impact factor: 2.357

Review 8.  Personalized cardiovascular medicine: concepts and methodological considerations.

Authors:  Henry Völzke; Carsten O Schmidt; Sebastian E Baumeister; Till Ittermann; Glenn Fung; Janina Krafczyk-Korth; Wolfgang Hoffmann; Matthias Schwab; Henriette E Meyer zu Schwabedissen; Marcus Dörr; Stephan B Felix; Wolfgang Lieb; Heyo K Kroemer
Journal:  Nat Rev Cardiol       Date:  2013-03-26       Impact factor: 32.419

Review 9.  Lercanidipine in hypertension.

Authors:  Claudio Borghi
Journal:  Vasc Health Risk Manag       Date:  2005

10.  High-sensitivity cardiac troponin T predicts nondipper hypertension in newly diagnosed hypertensive patients.

Authors:  Murat Çaylı; Mustafa Gür; Zafer Elbasan; Taner Şeker; Caner Türkoğlu; Onur Kaypaklı; Durmuş Y Şahin; Hakan Uçar; Ali Kıvrak; Nermin Y Koyunsever; Ömer Sen
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-08-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.